JMSLtd (7702) Stock Overview
Engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals in Japan, North America, Europe, China, South Korea, Thailand, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 3/6 |
7702 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Join community and earn perks
JMS Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥456.00 |
| 52 Week High | JP¥464.00 |
| 52 Week Low | JP¥418.00 |
| Beta | 0 |
| 1 Month Change | 6.54% |
| 3 Month Change | 5.07% |
| 1 Year Change | 5.07% |
| 3 Year Change | -21.51% |
| 5 Year Change | -42.79% |
| Change since IPO | -70.69% |
Recent News & Updates
Recent updates
Shareholder Returns
| 7702 | JP Medical Equipment | JP Market | |
|---|---|---|---|
| 7D | 2.5% | 2.2% | 2.1% |
| 1Y | 5.1% | 20.8% | 44.1% |
Return vs Industry: 7702 underperformed the JP Medical Equipment industry which returned 20.8% over the past year.
Return vs Market: 7702 underperformed the JP Market which returned 44.1% over the past year.
Price Volatility
| 7702 volatility | |
|---|---|
| 7702 Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 3.9% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in JP Market | 9.2% |
| 10% least volatile stocks in JP Market | 2.1% |
Stable Share Price: 7702 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7702's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1947 | 4,887 | Ryuji Katsura | www.jms.cc |
JMS Co.,Ltd. engages in the manufacture, sale, export, and import of medical devices and pharmaceuticals in Japan, North America, Europe, China, South Korea, Thailand, and internationally. It offers infusion and nutrition solutions, which includes needless access port, closed drug mixing and infusion system, infusion pump, and oral and enteral nutrition system for treatment and laboratory testing; and dialysis solutions including dialysis equipment for hemodialysis, peritoneal dialysis solution, and APD equipment that automatically performs the injection and discharge of peritoneal dialysis solution.
JMS Co.,Ltd. Fundamentals Summary
| 7702 fundamental statistics | |
|---|---|
| Market cap | JP¥11.19b |
| Earnings (TTM) | -JP¥783.00m |
| Revenue (TTM) | JP¥65.85b |
Is 7702 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 7702 income statement (TTM) | |
|---|---|
| Revenue | JP¥65.85b |
| Cost of Revenue | JP¥50.49b |
| Gross Profit | JP¥15.36b |
| Other Expenses | JP¥16.14b |
| Earnings | -JP¥783.00m |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
Aug 07, 2026
| Earnings per share (EPS) | -31.92 |
| Gross Margin | 23.32% |
| Net Profit Margin | -1.19% |
| Debt/Equity Ratio | 63.4% |
How did 7702 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/04 11:08 |
| End of Day Share Price | 2026/07/03 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
JMS Co.,Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Motoya Kohtani | Nomura Securities Co. Ltd. |